Dr T has confirmed somewhere else that new safety trials are not required and it can use the old data under the 505(b)(2) pathway.
Ann: Race Develops Improved IV Formulation of Zantrene, page-19
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.43 |
Change
-0.020(1.38%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.47 | $1.51 | $1.43 | $121.4K | 82.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10392 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.44 | 3057 | 3 |
View Market Depth
| Last trade - 15.51pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.44 |
Change
-0.020 ( 1.71 %) |
||||
| Open | High | Low | Volume | ||
| $1.49 | $1.50 | $1.43 | 16871 | ||
| Last updated 15.58pm 27/05/2024 ? | |||||
| RAC (ASX) Chart |